Immunotherapy for Renal Cell Carcinoma

Immunotherapy plays a significant role in the management of renal cell carcinoma (RCC) patients with metastatic disease because RCC is highly resistant to both chemotherapy and radiation therapy. Many reports illustrate various approaches to the treatment of RCC, such as cytokine-, antigen- or dendr...

Descripción completa

Detalles Bibliográficos
Autores principales: Itsumi, Momoe, Tatsugami, Katsunori
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022170/
https://www.ncbi.nlm.nih.gov/pubmed/21253521
http://dx.doi.org/10.1155/2010/284581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022170/
https://www.ncbi.nlm.nih.gov/pubmed/21253521
http://dx.doi.org/10.1155/2010/284581

Ejemplares similares